Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Testosterone
Drug ID BADD_D02170
Description Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.[A187114,L8983,L8935,L8938,L8986,L8989,L8992,L8995] Testosterone was isolated from samples and also synthesized in 1935.[A186943]
Indications and Usage Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]
Marketing Status approved; investigational
ATC Code G03BA03
DrugBank ID DB00624
KEGG ID D00075
MeSH ID D013739
PubChem ID 6013
TTD Drug ID D06XMU
NDC Product Code 0832-1120; 65089-0050; 43598-304; 49884-418; 63629-8455; 63629-9310; 0591-2925; 38779-2936; 43647-568; 43742-1436; 73774-014; 76003-1083; 43742-1242; 0245-0871; 62332-552; 70700-112; 76420-685; 76420-687; 76420-699; 24979-130; 45802-610; 0051-8462; 64380-151; 68180-943; 69097-363; 0591-2363; 0603-7831; 0009-5020; 44132-006; 49452-7658; 64025-0010; 45802-281; 0245-0872; 0023-5992; 63629-2125; 64380-152; 66887-001; 0591-2114; 0591-2924; 0591-2926; 0591-3216; 0832-1121; 51927-0267; 70492-002; 76420-684; 0009-0074; 12875-8248; 22552-0009; 49452-7652; 60592-721; 60870-0251; 16714-967; 17139-562; 63629-2124; 68180-941; 44132-008; 48087-0113; 51552-0029; 42667-5511; 63481-183; 63629-2352; 69238-1013; 0591-3217; 0591-3524; 38779-0163; 38779-2598; 82393-113; 24979-078; 45802-366; 66887-004; 51552-0564; 62991-2150; 76420-686; 16714-969; 45802-754; 49884-510; 62332-488; 69339-158; 0591-2921; 49452-7657; 16714-968; 0023-5990
UNII 3XMK78S47O
Synonyms Testosterone | 17-beta-Hydroxy-4-Androsten-3-one | 17 beta Hydroxy 4 Androsten 3 one | Androtop | Histerone | Sterotate | Sustanon | Androderm | Testoderm | Testolin | Testopel | Testosterone Sulfate | AndroGel | 8-Isotestosterone | 8 Isotestosterone | 17-beta-Hydroxy-8 alpha-4-Androsten-3-one | 17 beta Hydroxy 8 alpha 4 Androsten 3 one | Andropatch | Testim
Chemical Information
Molecular Formula C19H28O2
CAS Registry Number 58-22-0
SMILES CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Priapism24.04.12.007; 21.03.01.0050.000091%Not Available
Prostatic adenoma21.04.02.005; 16.36.01.001--Not Available
Prostatic disorder21.04.01.001--Not Available
Prostatic specific antigen increased13.23.01.003--Not Available
Prostatitis21.09.01.0010.000445%Not Available
Prothrombin level increased13.01.02.011--Not Available
Prothrombin time prolonged13.01.02.012--Not Available
Pruritus23.03.12.001--
Pruritus genital23.03.12.008; 21.10.01.002--Not Available
Pulmonary embolism24.01.06.001; 22.06.02.0010.048531%Not Available
Pulmonary infarction24.04.09.001; 22.06.02.0020.000772%Not Available
Pulmonary microemboli22.06.02.006; 24.01.06.006--Not Available
Pulmonary thrombosis24.01.06.002; 22.06.02.0030.000227%Not Available
Rash23.03.13.001--Not Available
Rash papular23.03.13.017--Not Available
Rash pustular23.03.10.003; 11.01.12.002--
Red blood cell count increased13.01.05.008--Not Available
Renal colic20.02.03.010--
Renal failure20.01.03.005--Not Available
Renal infarct24.01.11.004; 20.01.07.0080.000182%Not Available
Renal pain20.02.03.003--Not Available
Respiratory distress22.02.01.012--Not Available
Retinal artery occlusion24.01.07.003; 06.10.01.0050.000636%Not Available
Retinal vascular occlusion24.04.10.004; 06.10.01.0080.000091%Not Available
Retinal vein occlusion24.01.07.006; 06.10.01.0100.000473%Not Available
Rhinitis11.01.13.004; 22.07.03.006--
Rosacea23.02.08.001--Not Available
Rotator cuff syndrome12.01.07.018; 15.01.08.0020.000091%
Scab23.03.03.0040.000309%Not Available
Seborrhoeic dermatitis23.03.04.018--Not Available
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 19 Pages